The phage therapy paradigm: prêt-à-porter or sur-mesure?
Pharm Res
.
2011 Apr;28(4):934-7.
doi: 10.1007/s11095-010-0313-5.
Epub 2010 Nov 10.
Authors
Jean-Paul Pirnay
1
,
Daniel De Vos
,
Gilbert Verbeken
,
Maia Merabishvili
,
Nina Chanishvili
,
Mario Vaneechoutte
,
Martin Zizi
,
Geert Laire
,
Rob Lavigne
,
Isabelle Huys
,
Guy Van den Mooter
,
Angus Buckling
,
Laurent Debarbieux
,
Flavie Pouillot
,
Joana Azeredo
,
Elisabeth Kutter
,
Alain Dublanchet
,
Andrzej Górski
,
Revaz Adamia
Affiliation
1
Laboratory for Molecular and Cellular Technology, Burn Wound Centre, Queen Astrid Military Hospital, 1120, Brussels, Belgium.
PMID:
21063753
DOI:
10.1007/s11095-010-0313-5
No abstract available
MeSH terms
Anti-Bacterial Agents / therapeutic use
Bacterial Infections / drug therapy*
Bacteriophages*
Drug Industry
Humans
Substances
Anti-Bacterial Agents